Please login to the form below
Chugai
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Chugai's Japan sales performance.
AZ says target of $45bn sales by 2023 still achievable
patient prescriptions in the US and Germany and topping all biologics for asthma on that measure in Japan.
Novartis: pipeline will generate 60 filings in three years
The tally across the US, EU and Japan includes 26 projects that the drugmaker thinks have blockbuster sales potential that have already passed the proof-of-concept stage in clinical development. ... 1 – acquired as part of its $8.7bn takeover of AveXis
GSK’s says depot HIV injection works over three years
The new data, from the second of three pivotal trials intended to support a marketing application in Japan, showed that the drug was as effective as intravenous treatment with long-acting ... GSK says it remains on track to file for approval of
Roche’s new flu pill Xofluza approved in US
Discovered and developed by Shionogi, the drug is already approved in Japan, with Roche holding the marketing rights outside Japan and Taiwan.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Featured jobs
- Account Manager, Healthcare Public Affairs
-
£32, 000 – £40, 000 benefits
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Programme Director, Healthcare PR, Highly competitive package
-
Highly Competitive package
-
Senior Account Manager
-
Negotiable
-
Associate Medical Director
-
Highly Competitive
-
SENIOR MEDICAL WRITER IN ONCOLOGY
-
Up to £60, 000.00 pension bonus
-
Associate Director
-
£75, 000-90, 000
- Director, Market Access / HEOR - North-West
-
Negotiable
-
Senior Medical Writer
-
Competitive Salary
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Senior Account Director development role to Business Director, H...
-
Excellent package
-
Senior Medical Writer
-
Great salary and benefits
-
Consumer Health Account Director
-
Circa £60, 000 Gym and More
Subscribe to our email news alerts
- Golin opens office in Malaysia
- Synergy Vision to introduce four-day working week
- SWITCHED ONcology. Caregivers Focus Group Highlights. www.switchedoncology.com
- World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
- Life Sciences 4.0 - Antony Rawlins
- What is blockchain? - Richard Springham
PMHub
Life Healthcare Communications
Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...
Latest intelligence
- World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
- Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
- World Diabetes Day: Interaction and impact of diabetes on mental health
- For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
- Innovation in merger control and the impact on the pharmaceutical sector
- Is focusing on pipeline products enough to assess regulatory risks?...
Quick links
Infographics
